USA - May 24 2010
Stakeholders should understand and monitor developments in comparative research priorities, methodologies and communication of research findings.
Paul W. Radensky
USA - October 15 2009
The next chapter in the ongoing effort by the federal government to narrow the permissible uses of personal health information by entities engaged in the health care industry has arrived.
Stephen W. Bernstein, Bernadette M. Broccolo, Jennifer S. Geetter, Jerome (Jerry) B. Tichner
USA - July 6 2009
Personalised medicine promises to transform health care through innovative diagnostics that more precisely stratify patient populations, enabling health care providers to offer more tailored medical therapies, and will better inform treatment decisions.
Dov Greenbaum
USA - March 16 2009
In his weekly radio address on March 14, 2009, President Barack Obama announced the appointment of Dr. Margaret “Peggy” Hamburg as commissioner-designate of the U.S. Food and Drug Administration (FDA), and of Dr. Joshua Sharfstein as principal deputy commissioner.
Eric D. Hargan, Robert B. Nicholas